CAL
IDYA icon

Capital Advisors Ltd’s IDEAYA Biosciences IDYA Stock Holding History

Capital Advisors Ltd’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
1
– – ﹤0.01% 1465
2026
Q1 		$0 Hold
1
– – ﹤0.01% 1475
2025
Q4 		$0 Hold
1
– – ﹤0.01% 1451
2025
Q3 		$0 Hold
1
– – ﹤0.01% 1450
2025
Q2 		$0 Buy
+1
New +$19 ﹤0.01% 1473

Other funds holding IDYA

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
KFP
Kerr Financial Planning Fresno, California $89.6M AUM 72.71% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Capital Advisors Ltd's IDYA Position: Q2 2026 in Review

Capital Advisors Ltd held its IDEAYA Biosciences (IDYA) position steady in Q2 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1465.

Capital Advisors Ltd first reported a position in IDYA in Q2 2025 and has held it in 5 quarters since. 25 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Capital Advisors Ltd held 1 share of IDEAYA Biosciences worth $0 as of Q2 2026.
  • Capital Advisors Ltd left its IDEAYA Biosciences share count unchanged in Q2 2026.
  • IDEAYA Biosciences made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #1465 holding.
  • Capital Advisors Ltd first reported a position in IDEAYA Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 25 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.